LabConnect has launched a new digital platform that enables research sites to scan, record, and transmit participant sample data directly from mobile devices. The platform replaces the company’s prior digital pen system, marking a major step toward fully digitized sample capture and management.
Drawing on insights from millions of samples collected across global clinical trials, the new application eliminates paper requisitions, manual data entry, and fragmented courier processes—all common sources of lost samples and delayed shipments. According to CEO Wes Wheeler, the launch reflects LabConnect’s two decades of experience supporting decentralized clinical trials and its focus on improving site-level efficiency.
The smartphone- and tablet-compatible tool offers barcode scanning, multilingual support, and offline functionality to ensure consistent performance across diverse research environments. By digitizing data capture at the collection point, the system provides real-time visibility into sample location, status, and stability from collection through lab intake.
“By leveraging technology to streamline data capture at the site, we can significantly reduce queries and gain visibility into samples requiring priority processing,” said Charles Castano, chief technology officer at LabConnect. The system securely transfers site data into LabConnect’s validated LIMS environment, reducing manual steps and enabling faster, more reliable laboratory results.